Eric Bell

Eric Bell has a long and varied work experience. Eric began their career in 1990 as a Senior Manager at Ernst & Young, where they managed audits for a diverse base of industries. In 2004, they became the Vice President Corporate Controller at Pharsight, a software and consulting company in drug development. From 2012 to 2014, they served as Vice President, Corporate Controller at Harvest Power, Inc., an organics waste management and energy company with entities in the United States and Canada. In 2014, they moved to Cynosure, Inc. as Corporate Controller, where they worked until 2017. From 2017 to 2020, they held the role of Vice President Finance at NIGHTSTAR THERAPEUTICS (Acquired by Biogen June 2019), Genevant Sciences, and Tiburio Therapeutics. Eric is currently Vice President Finance and Controlling at Q32 Bio Inc.

Eric Bell received a Bachelor of Arts (BA) with an emphasis in Accounting from San Diego State University in the field of Accounting.